Diagnostic chain Dr Lal PathLabs on Tuesday said the board of its arm PathLabs Unifiers has approved acquisition of 70 per cent stake in Amins Pathology Referral Laboratory to strengthen its presence in Gujarat.
"We are pleased to announce the acquisition of a proprietorship concern, 'Amins Pathology Referral Laboratory' by our subsidiary PathLabs Unifiers Pvt Ltd which operates diagnostics networks in Vadodara, Gujarat," Dr Lal PathLabs CEO Om Manchanda said.
The acquisition will further strengthen the company's network in Gujarat and adjoining areas, he added.
Shares of Dr Lal PathLabs on Tuesday closed at Rs 1,367.20 per scrip on the BSE, down 1.52 per cent from its previous close.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app